Home / Blog / COVID-19 May Delay Some Cancer Treatments

COVID-19 May Delay Some Cancer Treatments

COVID-19 May Delay Some Cancer Treatments

Three most cancers experts within the United States who reviewed the record agreed that most cancers remedy would possibly require patient-doctor discussions at the moment.

Amy Moore directs science and analysis on the GO2 Foundation for Lung Cancer in Washington, D.C. She believes that lung most cancers sufferers, particularly, “may have elevated risk [of coronavirus infection] compared to other cancer types.”

Also, Moore mentioned, “hospital admissions and recurrent visits increase risk, reinforcing the importance of patients talking to their physicians regarding their own personal treatment plan.”

Dr. Wasif Saif is clinical director on the Northwell Health Cancer Institute in Lake Success, N.Y. He stressed out that the learn about inhabitants used to be very small, so the findings should be regarded as initial. But sure patterns emerged.

“Cancer patients were deemed to be at highest risk for severe complications, including admission to the intensive care unit requiring invasive ventilation, or death,” Saif famous. “Additionally, diagnosis of cancer was associated with a shorter time to development of severe events when compared to non-cancer patients.”

Because hospitals are particularly potent venues for coronavirus an infection, Saif believes that “tough decisions have to be made during this COVID-19 crisis whether to delay [cancer] treatment or simplify the treatment.”

But Dr. Adil Akhtar, director of inpatient medical operations at Karmanos Cancer Institute at McLaren Oakland in Pontiac, Mich., took a moderately other view.

He agreed that most cancers sufferers seem to be at upper odds of coronavirus an infection, however added that “cancer programs across the U.S. have already implemented robust infection and environmental controls, as per the [U.S. Centers for Disease Control and Prevention] guidelines.”

Akhtar added that, as in keeping with tips from the American Society of Clinical Oncology, at the moment “there’s no direct proof to beef up converting or withholding chemotherapy or immunotherapy in sufferers with most cancers.”

He believes it is tricky to resolve, on a person affected person foundation, whether or not the danger of contracting COVID-19 outweighs the ease to be received from persisted most cancers care.

So “clinical decisions should be individualized that consider factors such as the risk of cancer recurrence if therapy is delayed, modified or interrupted; the number of cycles of therapy already completed, and the patient’s tolerance of treatment,” Akhtar mentioned.


WebMD News from HealthDay


Sources

SOURCES: Amy Moore, Ph.D., director, science and analysis, GO2 Foundation for Lung Cancer, Washington, D.C.; Wasif Saif, M.D., deputy physician-in-chief and clinical director, Northwell Health Cancer Institute, Lake Success, N.Y.; Adil Akhtar, M.D., affiliate professor, Department of Medical Oncology and Hematology, Oakland University-William Beaumont School of Medicine, and  director, Inpatient Clinical Operations, Karmanos Cancer Institute at McLaren Oakland, Pontiac, Mich., and leader, Division of Palliative and End of Life Care, Michigan Health Professionals; March 25, 2020,JAMA Oncology




Copyright © 2013-2018 HealthDay. All rights reserved.

serve as pixelForFacebook()(i=e.fbq=serve as()i.callMethod?i.callMethod.observe(i,arguments):i.queue.push(arguments),e._fbqserve as pixelForTwitter()serve as pixelForPinterest(){!serve as()(),pintrk(“load”,”2618142259440″),pintrk(“page”),pintrk(“track”,”pagevisit”)}serve as pixelForReddit(){!serve as(e,t)(window,file),rdt(“init”,”t2_109a14pl”),rdt(“track”,”PageVisit”)}!serve as()()

Check Also

Guidelines on Delaying Cancer Surgery During COVID-19

Guidelines on Delaying Cancer Surgery During COVID-19 What your physician is studying on Medscape.com: …

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: